A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors
Clinical trial NCT03792750 · COMPLETED
Trial details
- NCT number
- NCT03792750
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-31
- Primary completion
- 2020-12-18
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.